chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Tested positive for COVID-19; Diarrhea; Rash; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for COVID-19), DIARRHOEA (Diarrhea), RASH (Rash) and FATIGUE (Fatigue) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concurrent medical conditions included COVID-19 since 16-Feb-2021 and No adverse event.   On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 15-Feb-2021, the patient experienced DIARRHOEA (Diarrhea), RASH (Rash) and FATIGUE (Fatigue). On 16-Feb-2021, the patient experienced COVID-19 (Tested positive for COVID-19). On 18-Feb-2021, DIARRHOEA (Diarrhea), RASH (Rash) and FATIGUE (Fatigue) had resolved. At the time of the report, COVID-19 (Tested positive for COVID-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Feb-2021, SARS-CoV-2 test: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-096144 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: Not specified On 29-Apr-2021: contact information updated
Diagnosed with COVID on 9/17/2021. Coughing for 6 days, fever, hard to sleep, fatigue, muscle aches, head ache, nausea.
Can't feel the lymph node; tender; lymph node swollen; fatigue; redness is getting down, but still there; redness around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Can't feel the lymph node), TENDERNESS (tender), LYMPHADENOPATHY (lymph node swollen), FATIGUE (fatigue) and VACCINATION SITE ERYTHEMA (redness is getting down, but still there) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (Can't feel the lymph node), TENDERNESS (tender), LYMPHADENOPATHY (lymph node swollen), FATIGUE (fatigue), VACCINATION SITE ERYTHEMA (redness is getting down, but still there) and VACCINATION SITE ERYTHEMA (redness around the injection site). At the time of the report, HYPOAESTHESIA (Can't feel the lymph node), TENDERNESS (tender), LYMPHADENOPATHY (lymph node swollen), FATIGUE (fatigue), VACCINATION SITE ERYTHEMA (redness is getting down, but still there) and VACCINATION SITE ERYTHEMA (redness around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant Medications were  provided by Reporter. No Treatment was provided by Reporter.   Reporter did not allow further contact
Woke up with pain in armpit and soreness in arm at injection site. Pain in armpit has continued throughout the day. Pain making movement very uncomfortable . If pain persists will follow up with doctor.
I had a fever that evening and thru the night into the following morning.  I have had ongoing EXTREME exhaustion and have been unable to return to work since Thur. April , 2021.
Exactly 12 or 13 hours after shot i had chills, high fever, severe muscular cramping (legs, upper back) .   Not naseaus yet.  Medium headache , severe fatigue, i had to crawl to the bathroom cause I couldn't stand up.     I'm writing this about 10:30 am and think I'm feeling a little better.
pt recv vax 2JUN95 morning; over next few day had inc erythema, warmth, tenderness 5-6cm w/2cm induration
approx 1 hr p/inject rash noted on head; approx 1 hr later pt screaming on/off for approx 2-3 hrs began severe hrs p/inject was seen in ER, t98.9; next day was seen @ MD office; didn't think it was a react to any of the immun;
The day following vaccine administration patient awakened with bilateral heel pain which progressed to pain in both ankles, wrist and left elbow over 24-72 hours.  Swelling in these joints noted 48-72 hours prior to presentation on 12/14/2011. Patient self-treatd with ibuprofen for pain. No fevers, muscle aches or fatigue.
Developed swollen red ring with rash at injection site.  Shortly after, developed rash which itched in the middle top of my back. Shortly after this the rash has continued to appear at different places on my body: shoulders, neck, arms, legs, etc.  It has been 4 weeks since the vaccine was administered and little spots continue to appear at various places on my body.
About 24 hours after injection, I started experiencing grogginess and anxiety. The next day, start feeling very unwell and experiencing symptoms of medication withdrawal (face tingling, brain fog, anxiety, inability to remember tasks) Lasted for one week. Saw doctor on 29th, she was unable to offer any advise other than watch symptoms and see if they resolved.
Cellulitis of the (L) deltoid arm at the site of injection. Rx Keflex x 5 days.
Temp to 100.1, headache, nausea, fatigue, myalgia
Pt. was administered TDAP, MENACTRA, HPV. About 3 min. after, she became pale (white), slid down in chair - non responsive. Became responsive as ice was applied to forehead. Still dazed & pale. Said I fainted. She yawned many times. Tried to go to sleep. B/P 50/40. After eating crackers, she left 25 min. later with her mother.
Symptomatic positive COVID result from 5/15/2021.  Headache, Congestion, Runny Nose,  Symptoms started 5.14.2021
Flu-like symptoms.  What was most concerning to pt was local reaction which was noted 2 days after immunization.  Pink hue, 1inx2in between where shot was given and right axillae.  No LAD noted but was tender.  No anaphylaxis symptoms.
feeling generally unwell; fatigue; arm redness; Lymph nodes in the arm swell up; soreness; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (feeling generally unwell), PAIN (soreness), LYMPHADENOPATHY (Lymph nodes in the arm swell up), FATIGUE (fatigue) and VACCINATION SITE ERYTHEMA (arm redness) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011J20A and 028L20A) for COVID-19 vaccination.     The patient's past medical history included Cholelithiasis (Gall stone dissolution drugs taken). Concurrent medical conditions included Anxiety (antidepressants were taken) since 2003, Psoriasis since 2004, Irritable bowel syndrome (Gastroparesis) since 2006 and Lactose intolerance. Concomitant products included CITALOPRAM HYDROBROMIDE (CELEXA [CITALOPRAM HYDROBROMIDE]) for Anxiety, COLESEVELAM HYDROCHLORIDE (WELCHOL) for Gastrointestinal disorder therapy.   On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Dec-2020, the patient experienced PAIN (soreness). On 05-Jan-2021, the patient experienced LYMPHADENOPATHY (Lymph nodes in the arm swell up). On an unknown date, the patient experienced MALAISE (feeling generally unwell), FATIGUE (fatigue) and VACCINATION SITE ERYTHEMA (arm redness). At the time of the report, MALAISE (feeling generally unwell), FATIGUE (fatigue) and VACCINATION SITE ERYTHEMA (arm redness) had resolved, PAIN (soreness) was resolving and LYMPHADENOPATHY (Lymph nodes in the arm swell up) had not resolved.            The patient reported treatment of events with acetaminophen (Tylenol).  Patient under went mammogram  and ultrasound but results were not reported.   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: follow-up received addition of current condition ,concomitant medication ,allergy to lactose,addition of three new event fatigue, malaise, vaccination site erythema
103.9 fever, excruciating headache, lymph nodes under both arms swollen and hurt, fatigue, hurt all over my body, nausea, injection site sore
Currently 32 6/7 weeks pregnant with EDD 2/19/21.  Acute onset palpitations at rest with HR 115 with most severe palpitations lasting 15 minutes, improved with Valsalva but HR remained 95-115 at rest for nearly 2 hours prior to returning to normal.  No prior cardiac history or history of palpitations.
mildly elevated heart rate compared to normal. not true tachycardia, but baseline typically in 60s, and was in 80s-90s for a few weeks. self limited
Patient was fine initially after shots.  Patients usually get the burning, tingling and numbness after shot.  Patient did tell me that after shot (Gardasil) mom looked very concerned on the side effects.  So I checked patient after 10 minutes.  No reaction at the time.  After 15 minutes, I checked patient to see if any reaction - none at time.  Advised patient and mother to make next appointment at front desk.  Patient then told mother her throat was hurting.  Mother told receptionist to see if that was ok.  Receptionist got me - then I proceeded to put patient back in room to get the doctor to examine her.  Mother told me she started to have a sore throat after vaccines were given.  I asked patient how she was feeling regarding her breathing.  She said (patient) she was fine.  Again I asked to see if maybe her throat felt like it was closing.  They all giggled and patient said I think I would know.  I interrupted the doctor with her next patient to inform her and mother came out and said her daughter felt like her throat was swollen.  The doctor then saw patient while I got the float nurse to do vitals and pulse ox.  Float nurse requested to report to room that patient was in.  Patient was jovial when arrived, asked how patient felt, stated she felt fine.  Took Pulse Ox (99), Pulse (92), Resp (24) and BP (90/60).  Asked if she had difficulty breathing.  Patient stated "no".  Lungs sound clear.
Had sudden onset of muscle and joint pain so severe that on waking the second day following shot was not able to get up and move around easily.  Pain focused on hands, fingers and knees, with lessened muscle pain after the first week but continued diffuse joint pain throughout entire body - all joints.  Fingers and hands have worsened to the point of locking and having limited mobility and strength.  Pt cannot form a fist  in either hand due to pain and stiffness.
stiff arm; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (stiff arm) and MYALGIA (sore arm) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     Concurrent medical conditions included Alcohol allergy, Caffeine, Drug allergy, Drug allergy, Drug allergy, Drug allergy and Macular degeneration. Concomitant products included VITAMIN B NOS, VITAMIN C [ASCORBIC ACID], COLECALCIFEROL (VITAMIN D3), MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) and SIMVASTATIN (AVASTINEE) for an unknown indication.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (stiff arm) and MYALGIA (sore arm). At the time of the report, MUSCULOSKELETAL STIFFNESS (stiff arm) and MYALGIA (sore arm) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Treatment information was not reported.   This case was linked to MOD-2021-262826 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Medical history updated. On 22-Jul-2021: Concomitant medication Avastin added.
Pt reports feeling nausea, cold sweat, blurry vision and R sided headache onset approximately 20 minutes after administration of vaccine.  Initial Vital Signs: 1319: BP-98/62 HR-62 SO2-98% RR- 18  1334: BP-120/68 HR- 69 sO2- 95% RR-17 Med Hx: Anxiety
Received Flu vaccine 10/16/20. Has experienced left shoulder pain that intensifies. Patient is now unable to lift left arm due to extreme shoulder immobility, muscle is very tense.
Patient was in the observation area after her first dose of the Covid vaccination. Patient reported to our staff that she felt her heart beating rapidly about 10 minutes after the vaccination. EMS was called. Patient was instructed to lie down on her back and feet elevated. The exact elevated heart rate was unknown. After about 2-3 minutes, the heart rate went down and measured about 84 BPM. Patient was starting to calm down at that point but remained lying down until EMS arrived. EMS checked her vitals and all were within normal limits. Patient walked out with EMS.
Initial and follow up information has been received from a wholesaler's representative, a certified medical assistant and a physician concerning a 77 year old retired male. On 26-SEP-2006, at 1:30 PM, the patient was vaccinated intramuscularly in the deltoid with the second dose of Pneumovax 23 (Lot# 651404/0352F). There were no illnesses noted at the time of vaccination. On 27-SEP-2006, at 7:30 AM, the patient developed mottled erythema, tenderness and swelling distal to the injection by a few centimeters and circumferential (previously reported as soreness, infection at the injection site, symptoms that consisted of severe subcutaneous edema which appeared down past the elbow near the forearm and edema was accompanied by severe pain. There was no reaction at the injection site. At the time of this report, the patient had recovered from the events (date unknown). No further information is available.
Nausea; Vomiting; Muscle pain; Fatigue; Chills; This is a spontaneous report from a contactable healthcare professional (patient). A 46-year-old female patient (non-pregnant) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EJ1686), intramuscular in left arm, on 11Jan2021 at 14:15, at a single dose, for COVID-19 immunization. The patient's medical history included hypertension, Hashimoto's, and allergies to sulfa. The patient had unspecified concomitant medications. The patient previously took the first dose of BNT162B2 (Lot Number: EK5730) on 19Dec2020 at 08:00 AM (intramuscular in left arm) for COVID-19 immunization. The patient was not diagnosed with COVID-19 prior vaccination. No other vaccine was administered in four weeks. The vaccine was administered in a hospital facility. On 12Jan2021 at 10:30 PM, the patient experienced nausea, vomiting, muscle pain, fatigue, and chills. No treatment was administered for the events. The patient had not been tested for COVID-19 post-vaccination. The patient was recovering from the events.
Information has been received from a licensed practical nurse concerning female college students 9exact number of patients unspecified) who were vaccinated intramuscularly with HPV rLi 6 11 16 18 VLP vaccine (yeast).  Subsequently the patients experienced injection site (deltoid) pain.  At the time of this report, the outcome of the event was unknown.  Further attempts are being made to identify the exact number of patients and identifiers of the patients involved in this report.
pt recv vax 24JUL96 & 24JUL96 pt devel paleness & dizziness during a finger stick for blood work;pt given 02;
Sore arm; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced pain in arm (Verbatim: Sore arm).  The outcome of the pain in arm was not reported.   It was unknown if the reporter considered the pain in arm to be related to Shingles vaccine.     It was unknown if the company considered the pain in arm to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 17-Sep-2023 This case was reported via interactive digital media. The reporter reported that her husband had a sore arm. This case was linked with US2023AMR129907, same reporter. The follow up could not be possible as no contact details were available.; Sender's Comments:  US-GSK-US2023AMR129907:Same reporter
Patient started complaining of legs being tired and aching.  Patient is involved in sports never had problems running.  After vaccine symptoms occurred.
On September 5th 2022 the patient, came to the clinic and said he needed to a Moderna booster shot. The staff member showed the "Moderna Covid 19 vaccine" bottle to the patient as we usually do, and administered the Moderna booster dose (Lot 063B22A). On September 27th the patient called us and said that he wanted the Bivalent Moderna, but instead he received the regular Moderna.
Lost hearing in right ear, severe imbalance problem. treated at hospital in Er 10/14/2002 by ear, nose, and throat specialist 10/21/2002. still suffering cannot walk without losing balance.
fever; nausea; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 12Mar2021 14:00 (Lot number: EN6198) as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: PALMITOYLETHANOLAMIDE taken for inflammation, start date: 2020 (ongoing); CBD OIL taken for inflammation, start date: 2020 (ongoing); VITAMIN D [COLECALCIFEROL], start date: 2018 (ongoing); LEXAPRO taken for anxiety, start date: 2017 (ongoing). Vaccination history included: Bnt162b2 (Dose no: 1, Time: 14:00, Anatomical Site of injection: Left arm, Lot no:EN6198), administration date: 09Feb2021, when the patient was 50 years old, for COVID-19 Immunization. The following information was reported: PYREXIA (non-serious), outcome "recovered", described as "fever"; NAUSEA (non-serious), outcome "recovered", described as "nausea". Relevant laboratory tests and procedures are available in the appropriate section.  Follow-up (10Jan2022): Follow-up attempts are completed. No further information is expected.
Pt states she developed HA, sweating, joint pain, fever, diarrhea on 3/23. (Vaccine given 3/11/15). Rash not hives) covered body beginning on chest on 3/25. Felt very fatigued as well.
Pt at present time on exchange program. Fever occurred 2 weeks before eruption of rash.
Extreme fatigue; Tenderness at injections site; Upset stomach; This is a spontaneous report from a contactable healthcare professional for a patient enrolled in Pfizer-sponsored program; this report is in regard to events reported in the patient medical history. A 60-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunisation.  The patient medical history and concomitant medications were not reported.  On an unspecified date the patient experienced extreme fatigue, tenderness at injections site and upset stomach that lingered for about a week. The patient got fatigue around 3:00 pm every day and took a nap which helped. The events were non-serious with outcome of unknown.  Information on the lot/batch number has been requested.
It did not swell up not much like in 1st dose; Whole right thigh area was painful; feels not recovered completely, lasted longer, still having some pain; whole right thigh area was painful along with right knee; This spontaneous case was reported by a consumer and describes the occurrence of JOINT SWELLING (It did not swell up not much like in 1st dose), PAIN IN EXTREMITY (Whole right thigh area was painful), CONDITION AGGRAVATED (feels not recovered completely, lasted longer, still having some pain) and ARTHRALGIA (whole right thigh area was painful along with right knee) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007B21A and 0011A21A) for COVID-19 vaccination.     The patient's past medical history included Post procedural infection (With unspecified complications) in 1978 and Knee operation (Right knee operation.) in 1978.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In March 2021, the patient experienced JOINT SWELLING (It did not swell up not much like in 1st dose), PAIN IN EXTREMITY (Whole right thigh area was painful), CONDITION AGGRAVATED (feels not recovered completely, lasted longer, still having some pain) and ARTHRALGIA (whole right thigh area was painful along with right knee). The patient was treated with Physical therapy for Joint swelling; Physical therapy for Pain in extremity; Physical therapy for Condition aggravated and Physical therapy for Arthralgia. In April 2021, JOINT SWELLING (It did not swell up not much like in 1st dose), PAIN IN EXTREMITY (Whole right thigh area was painful) and ARTHRALGIA (whole right thigh area was painful along with right knee) was resolving. At the time of the report, CONDITION AGGRAVATED (feels not recovered completely, lasted longer, still having some pain) was resolving.            Concomitant product use was not reported.   No additional treatment information was reported.   This case was linked to MOD-2021-195642 (Patient Link).
Pt presented to ER for c/o red, swollen "knot" on right thigh where DTaP, IPV given 06/10/02. ER dx'd cellulitis. Pt received a dose of Rocephin in ER and had f-u with us today. Redness had spread slightly since midnight. 2nd dose of Rocephin given 720mg. Rx given improving today for Omnicef 7 day course to begin 06/13/02. Beandryl, Motrin, icepacks/heat right thigh circumference 14" left thigh 13". Cellulitic area 4" x 6 1/2" redness, heat, induration.
pt recv vax; hard lump 3x3cm w/ red blotching; no pain or discomfort at site; lump apparent even 1 wk p/ inject;
Patient was receiving her first dose of the Pfizer COVID-19 vaccination and several minutes afterwards she developed dyspnea, intractable cough, nausea, sensation of her throat closing, difficulty breathing and sensation of facial swelling.  In the ED, the patient was administered epinephrine 0.3 mg IM and was given albuterol inhaler, Zofran 4 mg IV, Solu-Medrol 125 mg IV, 1 L fluid bolus and milligram Pepcid IV and 50 mg of Benadryl IV.     Pt received discharge instructions and stated understanding concerning medications, follow up care and when to seek emergent care. Pt PIV removed. Pt verbally acknowledged discharge instead of signing paperwork. Pt was ambulatory to discharge with all belongings and was escorted to the front of the bldg by staff.
Pt recvd 1st dose of Engerix-B 3OCT91 & on 4OCT91 less than 24 hrs p/vax pt exp soreness in arms where inject given & a pruritic rash on front trunk; required MD visit;
patient had redness stated few hours after vaccine and was worsening over time, he had to go ER and his provider prescribed  Keflex 500, and anit-histamin . Patient will be monitered for further symptoms.
Information has been received from a physician, via a company representative, concerning teenage female patient with a history of fainting when given injections, who was vaccinated (date unspecified) with the first dose, 0.5ml, of Gardasil. The physician reported that the patient fainted after the vaccine was administered, but at the time of this report had recovered (dates not specified). The patient sought unspecified medical attention. No further information is available.